▶️ Module 4 is out! It introduces 2 adaptive randomisation designs + 3 case studies: I-SPY 2, remap-cap & ATTACC CAP. Read about the content & speakers 👉🏾 mailchi.mp/ecraid/watch-m… Access the module for free 👉🏼 channel.ersnet.org/media-106923-e…

Did you know? 🤔 Infectious diseases are still a major threat to children globally. 🦠 Penta is developing solutions to fight #HIV, #Pneumonia, #Hepatitis, and more. Learn why our research matters 👉 bit.ly/penta-annual-r…

Eager to explore non-traditional #antimicrobials? 👀 Join us for our next #REVIVE webinar with Jennifer Schneider, Rida Mourtada Lytica Therapeutics and Gregorio Iraola kinzbio to have insights from three cases. 📅22 August 2024 🔗Free registration: attendee.gotowebinar.com/register/89356…

New research highlights the need to improve diagnostics to boost antibiotic stewardship and combat #AMR. Despite promising tech and efforts, challenges remain. Discover how experts suggest overcoming these obstacles: link.springer.com/article/10.100…

Get a closer look at the #ECRAIDBase studies remap-cap, POS-ARI-PC & POS-VAP in this postgrad course at #ERSCongress2024 🫁 Presented by Lennie Derde Ana C Hernandez Marc Bonten & Nguyen Tran; chaired by Eva Polverino & Maurizio Sanguinetti. ERS ESCMID European Commission

You can now receive notifications for new posts on Marc Bonten's blog 🔔 Subscribe here 👉🏼 letstalkscience.eu/subscribe #LetsTalkScience

We need a comprehensive, equitable and sustainable response to #AMR In the run-up to this year’s United Nations High-Level Meeting on AMR, read more about our perspective and key recommendations 👇 gardp.org/wp-content/upl…

Anezka & Marie loved the international & highly interactive format of the ESCMID / Ecraid 'Better Methods' postgrad course in Prague last year. Read the interview 👉🏼 ecraid.eu/news/participa… Join the 3rd edition of the course in Belgrade from 22-24 Oct 👉🏾 ecraid.eu/news/2024-post…

5 days remaining: ESCMID members with valid Full, Young Scientist, or LMIC Membership can apply for an attendance grant for the upcoming 'Better Methods' postgrad course. 📍 Belgrade 🇷🇸 📅 22-24 October 2024 Apply until 12 August 👉🏼 escmid.org/event-detail/b…

▶️ In Module 4 of our adaptive #clinicaltrial designs series Sofia S. Villar, carole mitnick, Matteo Cellamare, Lorenzo Guglielmetti & Scott Berry present 2 types of adaptive randomisation & 4 case studies: endTB I-SPY 2 remap-cap ATTACC CAP. Watch it 👉🏼 ecraid.eu/news/module-4-…

🚩 The Ecraid-managed #EPOXI trial on #mpox enrolled its first patient! This major milestone took place at Institute of Tropical Medicine Antwerp🇧🇪 on Friday. EPOXI is part of the 🇪🇺-funded MPX-RESPONSE project. It aims to enrol 150 participants in 8 EU countries. Read more 👉🏼 ecraid.eu/study/epoxi

Responding to Amber Dance's nature article featuring 3 examples of the #AMR crisis's depth and 5 solutions, Marc Bonten writes: "The good news is that those examples make no sense (to me); the bad news is that the solutions are far from innovative." letstalkscience.eu/2024/08/14/goo…

🚨 The World Health Organization (WHO) declared #mpox a global public health emergency for the second time in 2 years 👉🏼 who.int/news/item/14-0… This major development underscores the urgency of our mpox study EPOXI which began enrolling patients last week. Read more 👉🏾 ecraid.eu/news/epoxi-tri…

Read Marc Bonten's thoughts on an #mpox #clinicaltrial conducted in the DRC which, among other things, "demonstrates the value of maintaining #research infrastructure and collaborations to address future outbreaks".

The #EPOXI trial has successfully launched its first sites in Germany and Belgium. This randomized controlled trial, led by UMCU and Ecraid, will assess the efficacy and safety of our antiviral drug to treat adult #mpox patients.

Ever wondered what happens after patient tissue and mucus samples are collected? Follow the journey of a Laboratory of Medical Microbiology UA sample–from patient to petri dish–to learn how this helps refine treatments & explore new approaches to #infectiousdiseases. ecraid.eu/news/patient-p…